1. Home
  2. BNL vs DYN Comparison

BNL vs DYN Comparison

Compare BNL & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadstone Net Lease Inc.

BNL

Broadstone Net Lease Inc.

HOLD

Current Price

$22.35

Market Cap

4.1B

Sector

Real Estate

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$23.37

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BNL
DYN
Founded
2007
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.9B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
BNL
DYN
Price
$22.35
$23.37
Analyst Decision
Buy
Strong Buy
Analyst Count
9
14
Target Price
$20.22
$37.00
AVG Volume (30 Days)
2.2M
2.4M
Earning Date
04-29-2026
05-04-2026
Dividend Yield
5.87%
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$454,138,000.00
N/A
Revenue This Year
$7.93
N/A
Revenue Next Year
$5.45
N/A
P/E Ratio
$91.06
N/A
Revenue Growth
5.17
N/A
52 Week Low
$15.67
$8.88
52 Week High
$22.15
$25.00

Technical Indicators

Market Signals
Indicator
BNL
DYN
Relative Strength Index (RSI) 68.29 62.65
Support Level $19.60 $16.47
Resistance Level N/A $24.52
Average True Range (ATR) 0.38 1.18
MACD 0.07 0.03
Stochastic Oscillator 98.17 70.07

Price Performance

Historical Comparison
BNL
DYN

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: